Follow the Drugs Made In America Acquisition Corp. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.1bn. The latest transaction was disclosed on 18 February 2025 (Acquisition). Among the most active insiders: Stockwell Lynn. The full history is openly available.
8
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 7,123 of 29,063 companies
64.3
score / 100
Value
71
Quality
58
FCF yld14%
Earn yld0.5%
EV/EBITDA5.0x
ROE12%
Gross mgn58%
Net mgn0.5%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Drugs Made In America Acquisition Corp. es una sociedad de adquisición con fines especiales centrada en el sector farmacéutico. Su objetivo es identificar y adquirir empresas innovadoras dentro de este campo.